Reconsideration of drug repurposing through artificial intelligence program for the treatment of the novel coronavirus
Lakshmi Narasimha Gunturu1, Girirajasekhar Dornadula2 and Raghavendra Naveen Nimbagal3, 1Scientimed Solutions Private Limited, Mumbai, Maharashtra, India, 2Department of Pharmacy Practice, Annamacharya College of Pharmacy, Rajampeta, Andhra Pradesh, India, 3Department of Pharmaceutics, Sri Adichunchanagiri College of Pharmacy, Adichunchanagiri University, B.G. Nagar, Mandya, Karnataka, India
Abstract
The coronavirus caused by the severe acute respiratory syndrome 2 (SARS-CoV-2) virus that began in December 2019 in Wuhan, China, created havoc among the public and healthcare professionals. Since its outbreak, ...
Get Artificial Intelligence in Healthcare and COVID-19 now with the O’Reilly learning platform.
O’Reilly members experience books, live events, courses curated by job role, and more from O’Reilly and nearly 200 top publishers.
